Pregunta del mes | Kern Pharma Biologics

Guidelines for Treating Rheumatologic Diseases With Biosimilars

0
0 / 5 (0 votos)

Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases. Use of these agents by clinicians will help increase the number of available treatment…

Fuente: Rheumatology Advisor

Seguir leyendo